Valuation : Amerise Biosciences Limited

Market Cap	3.9Cr 4L 4L 3L 3L 6L 6L 39.25L 15.27L 1.98Cr 15.38L 15.05L 6.54Cr	P/E 2024	-29.8x	P/E 2025	1,056x
Enterprise Value	3.88Cr 4L 4L 3L 3L 6L 6L 39.02L 15.18L 1.97Cr 15.29L 14.96L 6.51Cr	EV / Sales 2024	121x	EV / Sales 2025	31.9x
Free-Float	64.18%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Amerise Biosciences Limited

Dynamic Chart

Latest news : Amerise Biosciences Limited

04/08	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05/05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
03/02	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02/02	Amerise Biosciences appoints Albert Hines as CFO	RE
02/02	Amerise Biosciences Limited Announces Chief Financial Officer Changes, Effective February 2, 2026	CI
02/02	Amerise Biosciences Limited Announces Board Changes, Effective February 2, 2026	CI
05/11	Amerise Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
24/25/24	Amerise Biosciences Limited Appoints Kelash Bunkar as Independent Director, Effective 23 September 2025	CI
24/25/24	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
19/25/19	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
03/25/03	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
03/25/03	Amerise Biosciences Limited Announces Resignation of Niraj Vaghela as Independent Director	CI
28/25/28	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI

More news

Quotes and Performance

1 day	-4.76%
1 week	-3.61%
Current month	-20.79%
1 month	-20.79%
3 months	+12.68%
6 months	+29.03%
Current year	+31.15%

More quotes

Price Extremes

1 week	0.8	0.84
1 month	0.8	1.03
Current year	0.5	1.03
1 year	0.5	1.03
3 years	0.5	1.45
5 years	0.5	2.73
10 years	0.5	2.73

More quotes

Managers and Directors : Amerise Biosciences Limited

Manager	Title	Age	Since
Albert Hines DFI	Director of Finance/CFO	-	02/02/2026
Soni Pandiya CMP	Compliance Officer	-	15/04/2026

Director	Title	Age	Since
Manisha Maneklal Patel BRD	Director/Board Member	57	24/06/2019
Niraj Vijaybbai Vaghela BRD	Director/Board Member	29	23/07/2022
Albert Hines BRD	Director/Board Member	-	02/02/2026

More insiders

Shell Companies

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMERISE BIOSCIENCES LIMITED	-4.76%	-3.61%	+15.94%	+25.00%	6L
CHURCHILL CAPITAL CORP XI	-4.26%	-4.97%	-	-	78Cr
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.10%	0.00%	-	-	65Cr
CHURCHILL CAPITAL CORP XII	-0.28%	+0.56%	-	-	60Cr
BAIN CAPITAL GSS INVESTMENT CORP.	+0.49%	+0.10%	-	-	60Cr
CANTOR EQUITY PARTNERS IV, INC.	+0.05%	-0.24%	+2.57%	-	59Cr
CENTIEL AG	-1.71%	-3.36%	+273.54%	-79.57%	59Cr
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+1.65%	+0.61%	-	-	57Cr
CHURCHILL CAPITAL CORP XIII	0.00%	+0.76%	-	-	51Cr
Average	-1.16%	-1.30%	+97.35%	-27.29%	54.35Cr
Weighted average by Cap.	-0.87%	-1.72%	+137.97%	-79.47%

See all sector performances

Financials

	2024	2025
Net sales	4L 3.77T 3.25T 3.05T 2.78T 5.23T 5.27T 36.15T 14.06T 2L 14.17T 13.86T 6L	18.8L 19.76T 17.01T 15.97T 14.58T 27.39T 27.59T 2L 73.65T 10L 74.19T 72.57T 31.57L
Net income	-14.61L -15.35T -13.22T -12.41T -11.33T -21.29T -21.44T -1L -57.23T -7L -57.65T -56.4T -24.53L	57T 599.06 515.79 484.31 442.09 830.52 836.47 5.74T 2.23T 28.9T 2.25T 2.2T 95.7T
Net Debt	-2L -2.22T -1.91T -1.79T -1.64T -3.07T -3.1T -21.24T -8.27T -1L -8.33T -8.15T -4L	-2L -2.33T -2.01T -1.89T -1.72T -3.23T -3.26T -22.35T -8.7T -1L -8.76T -8.57T -4L